Anti-IgE (omalizumab) inhibits late-phase reactions and inflammatory cells after repeat skin allergen challenge

Authors:
  • AKA. Barry Kay
    A. Barry Kay

Abstract
No abstract available

This publication has 27 references indexed in Scilit: